PFC@O<sub>2</sub> Targets HIF-1α to Reverse the Immunosuppressive TME in OSCC
As a typical hallmark of solid tumors, hypoxia affects the effects of tumor radiotherapy, chemotherapy, and photodynamic therapy. Therefore, targeting the hypoxic tumor microenvironment (TME) is a promising treatment strategy for cancer therapy. Here, we prepared an Albumin Human Serum (HSA)-coated...
Main Authors: | Zhou Lan, Ke-Long Zou, Hao Cui, Hao Chen, Yu-Yue Zhao, Guang-Tao Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/2/560 |
Similar Items
-
Mechanisms of HIF-driven immunosuppression in tumour microenvironment
by: Shinjini Bandopadhyay, et al.
Published: (2023-08-01) -
Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy
by: Leah Davis, et al.
Published: (2022-02-01) -
HIF-1α and HIF-2α Differently Regulate the Radiation Sensitivity of NSCLC Cells
by: Eloy Moreno Roig, et al.
Published: (2019-01-01) -
Differential Contribution of N- and C-Terminal Regions of HIF1α and HIF2α to Their Target Gene Selectivity
by: Antonio Bouthelier, et al.
Published: (2020-12-01) -
HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
by: Kiichi Hirota
Published: (2021-04-01)